For a change, there is good news to report. Even more remarkable, the good news comes from the federal government! Now that’s really something to cheer about!
The Center for Disease Control and Prevention (CDC) reported recently that cancer mortality among children has fallen by nearly 25% over the last two decades. The editorial board of The Wall Street Journal tells us that cancer ranks among the top five causes of death for youth under the age of 20. While pediatric deaths from overdoses, homicides and firearm injuries have recently climbed, cancer mortality has been steadily declining for two decades, especially for younger children.
The death rate for leukemia, the most common childhood cancer, fell by 47% between 2001 and 2021. Progress for brain cancer—now the leading pediatric cancer killer—has been slower, but mortality has still decreased by 11% over the last decade. Thank improved treatments, including monoclonal antibodies and medicines that block enzymes that cause uncontrolled cell growth.
Naturally, progressives have found something to complain about in these statistics. They say that racial disparities in cancer deaths have increased. Mortality rates were roughly similar for whites, Hispanics and blacks in 2011. But then progress stalled for blacks and Hispanics while continuing for whites. By 2021 the death rate for white children was about 16% lower than for blacks and Hispanics.
One explanation may be that Medicaid patients lack access to premier oncologists and have to wait longer for appointments with specialists to get diagnosed. A Journal of the American Medical Association study last year showed that many high-quality cancer centers don’t accept Medicaid patients because of its low payment rates. Facilities with high Medicaid access also had low quality ratings.
“Despite a large increase in the number of Medicaid-insured patients, most factors that limit a hospital or physician’s participation in Medicaid have not changed,” the senior author noted. “These include low reimbursement, high administrative burden, and limited specialist participation in managed care organization networks.”
The same is true for ObamaCare. Not all health insurance is the same. Medicaid is the worst healthcare insurance you can have and ObamaCare is not much better. Both systems have poor access to the best doctors and the best hospitals. As long as payments from these insurance plans lag well behind other insurance, this situation won’t change.
Meanwhile, the Inflation Reduction Act will discourage drug makers from pursuing new treatment indications for pediatric cancers after receiving approval for adult patients since the price controls will de facto apply to Medicaid. The disincentive is especially great for small molecule drugs that have been critical to reducing pediatric cancer deaths.
This is still good news for children who can access the best medical treatment in this country. But it’s also exposing the deficiencies of the federal government-controlled healthcare systems of Medicaid and ObamaCare. No matter what the government wants you to believe, their healthcare systems are still inferior.